BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

896 related articles for article (PubMed ID: 34526055)

  • 1. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment.
    Qiu S; Palavicini JP; Wang J; Gonzalez NS; He S; Dustin E; Zou C; Ding L; Bhattacharjee A; Van Skike CE; Galvan V; Dupree JL; Han X
    Mol Neurodegener; 2021 Sep; 16(1):64. PubMed ID: 34526055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel molecular insights into the critical role of sulfatide in myelin maintenance/function.
    Palavicini JP; Wang C; Chen L; Ahmar S; Higuera JD; Dupree JL; Han X
    J Neurochem; 2016 Oct; 139(1):40-54. PubMed ID: 27417284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfatide Deficiency, an Early Alzheimer's Lipidomic Signature, Causes Brain Ventricular Enlargement in the Absence of Classical Neuropathological Hallmarks.
    Palavicini JP; Ding L; Pan M; Qiu S; Wang H; Shen Q; Dupree JL; Han X
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial Sulfatides and Neuronal Complex Gangliosides Are Functionally Interdependent in Maintaining Myelinating Axon Integrity.
    McGonigal R; Barrie JA; Yao D; McLaughlin M; Cunningham ME; Rowan EG; Willison HJ
    J Neurosci; 2019 Jan; 39(1):63-77. PubMed ID: 30446529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer's disease.
    Cheng H; Zhou Y; Holtzman DM; Han X
    Neurobiol Aging; 2010 Jul; 31(7):1188-96. PubMed ID: 18762354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice.
    Kaya I; Jennische E; Lange S; Tarik Baykal A; Malmberg P; Fletcher JS
    J Neurochem; 2020 Jul; 154(1):84-98. PubMed ID: 32141089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer's disease.
    Han X
    Mol Neurobiol; 2010 Jun; 41(2-3):97-106. PubMed ID: 20052565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer's disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling.
    Zheng JY; Sun J; Ji CM; Shen L; Chen ZJ; Xie P; Sun YZ; Yu RT
    Neurobiol Aging; 2017 Jun; 54():112-132. PubMed ID: 28366226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult-Onset CNS Sulfatide Deficiency Causes Sex-Dependent Metabolic Disruption in Aging.
    Qiu S; He S; Wang J; Wang H; Bhattacharjee A; Li X; Saeed M; Dupree JL; Han X
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy.
    Taylor X; Cisternas P; You Y; You Y; Xiang S; Marambio Y; Zhang J; Vidal R; Lasagna-Reeves CA
    J Neuroinflammation; 2020 Jul; 17(1):223. PubMed ID: 32711525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
    Lantz MJ; Roberts AM; Delgado DD; Nichols RA
    J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Amyloid-β (Aβ)-Induced Cognitive Impairment and Neuroinflammation in CHI3L1 Knockout Mice through Downregulation of ERK-PTX3 Pathway.
    Ham HJ; Lee YS; Koo JK; Yun J; Son DJ; Han SB; Hong JT
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in mouse brain lipidome after disruption of CST gene: a lipidomics study.
    Wang C; Wang M; Zhou Y; Dupree JL; Han X
    Mol Neurobiol; 2014 Aug; 50(1):88-96. PubMed ID: 24395133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult-onset depletion of sulfatide leads to axonal degeneration with relative myelin sparing.
    Dustin E; McQuiston AR; Honke K; Palavicini JP; Han X; Dupree JL
    Glia; 2023 Sep; 71(9):2285-2303. PubMed ID: 37283058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer's disease: a tale of shotgun lipidomics.
    Han X
    J Neurochem; 2007 Nov; 103 Suppl 1(Suppl 1):171-9. PubMed ID: 17986152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic deletion of astrocytic calcineurin B1 prevents cognitive impairment and neuropathology development in acute and chronic mouse models of Alzheimer's disease.
    Tapella L; Dematteis G; La Vitola P; Leva S; Tonelli E; Raddi M; Delconti M; Dacomo L; La Macchia A; Murari E; Talmon M; Malecka J; Chrostek G; Grilli M; Colombo L; Salmona M; Forloni G; Genazzani AA; Balducci C; Lim D
    Glia; 2024 May; 72(5):899-915. PubMed ID: 38288580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astragaloside IV Ameliorates Cognitive Impairment and Neuroinflammation in an Oligomeric Aβ Induced Alzheimer's Disease Mouse Model via Inhibition of Microglial Activation and NADPH Oxidase Expression.
    Chen F; Yang D; Cheng XY; Yang H; Yang XH; Liu HT; Wang R; Zheng P; Yao Y; Li J
    Biol Pharm Bull; 2021 Nov; 44(11):1688-1696. PubMed ID: 34433707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.
    Yin Z; Raj D; Saiepour N; Van Dam D; Brouwer N; Holtman IR; Eggen BJL; Möller T; Tamm JA; Abdourahman A; Hol EM; Kamphuis W; Bayer TA; De Deyn PP; Boddeke E
    Neurobiol Aging; 2017 Jul; 55():115-122. PubMed ID: 28434692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis.
    Han X; M Holtzman D; McKeel DW; Kelley J; Morris JC
    J Neurochem; 2002 Aug; 82(4):809-18. PubMed ID: 12358786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.